Pregled bibliografske jedinice broj: 24919
Drug interactions of H2 - Receptor Antagonists Involving Cytochrome P450 (CYPs) Enzymes: From the Lab to the Clinic
Drug interactions of H2 - Receptor Antagonists Involving Cytochrome P450 (CYPs) Enzymes: From the Lab to the Clinic // Croatian medical journal, 40 (1999), 3; 357-367 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 24919 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Drug interactions of H2 - Receptor Antagonists Involving Cytochrome P450 (CYPs) Enzymes: From the Lab to the Clinic
Autori
Rendić, Slobodan
Izvornik
Croatian medical journal (0353-9504) 40
(1999), 3;
357-367
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
H2-receptor antagonists ; cytochromes P450 ; in vitro and in vivo studies ; drug-drug interactions
Sažetak
This paper reviews the main steps in the research of the interactions of H2-receptor antagonist drugs with cytochrome P450 (CYP). Cimetidine, ranitidine and related compounds are used as examples. The results from in vitro studies are related to the observed clinically significant in vivo drug-drug and drug-chemical interactions. Uses of the in vitro results are discussed for the interpretation and possible prediction of drug-drug interactions, which may be important in developing new drugs. Other approach in the use of the in vitro data is to prevent the undesirable and toxic actions of drugs related to the catalytic activity of CYP enzymes. In the case of H2- receptor antagonists, the inhibition of the metabolic reactions due to the binding of the drugs with the enzymes was used to avoid side effects of co-administered drugs. The in vitro metabolic studies using recombinant human as well as animal CYP enzymes as model systems are now widely used when designing new drugs with improved therapeutic properties.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
006241
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Slobodan Rendić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE